Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 22:15:17562848221090820.
doi: 10.1177/17562848221090820. eCollection 2022.

Efficacy and safety of endoscopic papillectomy: a multicenter, retrospective, cohort study on 227 patients

Hannah Gondran  1 , Nicolas Musquer  1 , Enrique Perez-Cuadrado-Robles  2 , Pierre Henri Deprez  3 , François Buisson  4 , Arthur Berger  4 , Elodie Cesbron-Métivier  4 , Timothee Wallenhorst  5 , Nicolas David  6 , Franck Cholet  6 , Bastien Perrot  7 , Lucille Quénéhervé  6 , Emmanuel Coron  8
Affiliations

Efficacy and safety of endoscopic papillectomy: a multicenter, retrospective, cohort study on 227 patients

Hannah Gondran et al. Therap Adv Gastroenterol. .

Abstract

Background: Endoscopic papillectomy is a minimally invasive treatment for benign tumors of the ampulla of Vater or early ampullary carcinoma. However, reported recurrence rates are significant and risk factors for recurrence are unclear.

Objective: The aims of this study were to evaluate the efficacy and safety of endoscopic papillectomy and to identify risk factors for recurrence and adverse events.

Methods: All patients who underwent endoscopic papillectomy at five tertiary referral centers between January 2008 and December 2018 were included. Recurrence was defined as the detection of residue on one of the follow-up endoscopies. Treatment success was defined as the absence of tumor residue on the last follow-up endoscopy.

Results: A total of 227 patients were included. The resections were en bloc in 64.8% of cases. The mean lesion size was 20 mm (range: 3-80) with lateral extension in 23.3% of cases. R0 resection was achieved in 45.3% of cases. The recurrence rate was 30.6%, and 60.7% of recurrences were successfully treated with additional endoscopic treatment. Finally, treatment success was achieved in 82.8% of patients with a median follow-up time of 22.3 months. R1 resection, intraductal invasion, and tumor size > 2 cm were associated with local recurrence. Adverse events occurred in 36.6% of patients and included pancreatitis (17.6%), post-procedural hemorrhage (11.0%), perforation (5.2%), and biliary stenosis (2.6%). The mortality rate was 0.9%.

Conclusion: Endoscopic papillectomy is an effective and relatively well-tolerated treatment for localized ampullary tumors. In this series, R1 resection, intraductal invasion, and lesion size > 2 cm were associated with local recurrence.

Keywords: ampullary tumor; endoscopic papillectomy; endoscopic resection; post-ERCP pancreatitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Example of an endoscopic papillectomy procedure for ampullary adenoma with high-grade dysplasia: (a) Inspection of the lesion. (b) Positioning of the snare at the oral side of the ampulla. (c) Capture of the lesion and resection. (d) Retrieval of the resected specimen. (e) Inspection of the scar: biliary orifice (left arrow) and pancreatic orifice (right arrow). (f) Placement of a pancreatic stent and a biliary stent.
Figure 2.
Figure 2.
Flow chart describing the study flow from endoscopic procedure to the end of follow-up.
See this image and copyright information in PMC

References

    1. Kimura W, Ohtsubo K. Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer 1988; 61: 1394–1402. - PubMed
    1. Spadaccini M, Fugazza A, Frazzoni L, et al.. Endoscopic papillectomy for neoplastic ampullary lesions: a systematic review with pooled analysis. United European Gastroenterol J 2020; 8: 44–51. - PMC - PubMed
    1. Martin JA, Haber GB. Ampullary adenoma: clinical manifestations, diagnosis, and treatment. Gastrointest Endosc Clin N Am 2003; 13: 649–669. - PubMed
    1. Tran TC, Vitale GC. Ampullary tumors: endoscopic versus operative management. Surg Innov 2004; 11: 255–263. - PubMed
    1. Bourgouin S, Ewald J, Mancini J, et al.. Predictive factors of severe complications for ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: multivariate analysis of a 10-year multicentre retrospective series. Surgeon 2017; 15: 251–258. - PubMed